Correction to: The first-in-class alkylating deacetylase inhibitor molecule tinostamustine shows antitumor effects and is synergistic with radiotherapy in preclinical models of glioblastoma.
作者: Festuccia CMancini AColapietro AGravina G LVitale FMarampon FDelle Monache SPompili SCristiano LVetuschi ATombolini VChen YMehrling T
作者单位: 1Laboratory of Radiobiology, Department of Applied Clinical Sciences and Biotechnologies, University of L'Aquila, L'Aquila, Italy. claudio.festuccia@univaq.it.
2Laboratory of Radiobiology, Department of Applied Clinical Sciences and Biotechnologies, University of L'Aquila, L'Aquila, Italy.
3Division of Radiotherapy, Department of Applied Clinical Sciences and Biotechnologies, University of L'Aquila, L'Aquila, Italy.
4Division of Neurosciences, Department of Applied Clinical Sciences and Biotechnologies, University of L'Aquila, L'Aquila, Italy.
5Division of Applied Biology, Department of Applied Clinical Sciences and Biotechnol
刊名: Journal of hematology & oncology, 2018, Vol.11 (1), pp.38
来源数据库: PubMed Journal
DOI: 10.1186/s13045-018-0587-3
原始语种摘要: The original article [1] contained an error whereby Fig. 4 displayed incorrect magnification scales.
全文获取路径: PubMed  (合作)
分享到:
来源刊物:
影响因子:4.458 (2012)

×
关键词翻译
关键词翻译
  • glioblastoma 成胶质细胞瘤
  • antitumor 抗癌的
  • deacetylase 脱乙酰基酶
  • preclinical 临证前期的
  • synergistic 协同的
  • radiotherapy 放射线疗法
  • alkylating 烷基化的
  • molecule 分子
  • magnification 放大
  • whereby 借此